By Siddhi Mahatole Sept 8 (Reuters) – Boston Scientific said on Tuesday it no longer expects to meet its previously issued third-quarter and full-year 2026 sales and adjusted profit forecasts, after a
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Qualcomm strikes AI chip deal with Amazon, offers right to buy about $4 billion in stock
Sept 8 (Reuters) - Qualcomm on Tuesday reached a deal to develop custom chips with…
Air traffic control issue disrupts departing flights at major UK airports
LONDON, Sept 8 (Reuters) - Some departing flights at major British airports were disrupted on…
Green Leaf Hospital Honored with MY FM Award for Multispecialty Healthcare Excellence
Chief Hospital Administrator Mr. Gopalsingh Solanki receives the honour on behalf of Green Leaf Hospital.…
